$50 for your first 3 months Get the print edition and steer from crisis to recovery
Add this topic to your myFT Digest for news straight to your inbox
Tax gain helps Canadian drugmaker post first-quarter profit despite sliding sales
Shares in Canadian drugmaker tumble after discussions with Japan’s Takeda collapse
Papa suffers 26% slump in value of stock bought after he joined drugmaker in summer
Michael Pearson insists he remains confident of drugmaker’s prospects despite stock sale
New chief executive will consider pulling the plug on unprofitable agreement within months
Drugmaker’s shares plunge as it misses lowered profit forecasts
Directors look to industry veteran to stabilise scandal-hit drugmaker
Joe Papa bought $221,568 holding before rival made $29bn bid
International Edition
